[French practical guidelines for the diagnosis and management of IPF - 2021 update, full version].

V Cottin, P Bonniaud, J Cadranel, B Crestani,S Jouneau, S Marchand-Adam, H Nunes,L Wémeau-Stervinou, E Bergot, E Blanchard,R Borie,A Bourdin,C Chenivesse,A Clément, E Gomez, A Gondouin, S Hirschi, F Lebargy,C-H Marquette, D Montani, G Prévot, S Quetant,M Reynaud-Gaubert, M Salaun,O Sanchez,B Trumbic, K Berkani,P-Y Brillet, M Campana, L Chalabreysse, G Chatté, D Debieuvre,G Ferretti,J-M Fourrier,N Just, M Kambouchner, B Legrand,F Le Guillou,J-P Lhuillier, A Mehdaoui,J-M Naccache, C Paganon, M Rémy-Jardin,S Si-Mohamed, P Terrioux

Revue des maladies respiratoires(2022)

引用 3|浏览1
暂无评分
摘要
BACKGROUND:Since the previous French guidelines were published in 2017, substantial additional knowledge about idiopathic pulmonary fibrosis has accumulated. METHODS:Under the auspices of the French-speaking Learned Society of Pulmonology and at the initiative of the coordinating reference center, practical guidelines for treatment of rare pulmonary diseases have been established. They were elaborated by groups of writers, reviewers and coordinators with the help of the OrphaLung network, as well as pulmonologists with varying practice modalities, radiologists, pathologists, a general practitioner, a head nurse, and a patients' association. The method was developed according to rules entitled "Good clinical practice" in the overall framework of the "Guidelines for clinical practice" of the official French health authority (HAS), taking into account the results of an online vote using a Likert scale. RESULTS:After analysis of the literature, 54 recommendations were formulated, improved, and validated by the working groups. The recommendations covered a wide-ranging aspects of the disease and its treatment: epidemiology, diagnostic modalities, quality criteria and interpretation of chest CT, indication and modalities of lung biopsy, etiologic workup, approach to familial disease entailing indications and modalities of genetic testing, evaluation of possible functional impairments and prognosis, indications for and use of antifibrotic therapy, lung transplantation, symptom management, comorbidities and complications, treatment of chronic respiratory failure, diagnosis and management of acute exacerbations of fibrosis. CONCLUSION:These evidence-based guidelines are aimed at guiding the diagnosis and the management in clinical practice of idiopathic pulmonary fibrosis.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要